Browsing by Subject "A61P 7/02"
Now showing items 1-4 of 4
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-11-02)The present invention relates to a method and apparatus for isolating anticoagulant heparin or heparan sulfate by binding the anticoagulant heparin or anticoagulant heparan sulfate onto an affinity matrix and separating ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-12-28)A method of achieving safe and effective treatment or prevention of potentially harmful blood clots, or in inhibiting the coagulation of blood when so desired such as during a wide array of disease conditions including ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-07-02)A method of inhibiting fibrin clot formation is provided. The decorin protein, peptide, or related fragments are found to bind fibrinogen in the presence of Zinc (Zn2+), thus preventing the formation of fibrin clots. The ...